Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EXACT Sciences
MedTech
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Abbott has signed up to buy Exact Sciences in the largest diagnostics deal to date, acquiring the maker of the Cologuard at-home screening test.
Conor Hale
Nov 20, 2025 10:30am
Exact Sciences rolls out Cancerguard multi-cancer blood test
Sep 11, 2025 1:00pm
Exact Sciences plans 'transformative year' with new cancer tests
May 1, 2025 4:05pm
Exact Sciences kicks off launch of next-gen Cologuard Plus test
Mar 31, 2025 6:00am
FDA approves Exact Sciences’ next-gen Cologuard Plus home test
Oct 4, 2024 12:30pm
Exact Sciences presents early colorectal cancer blood test data
Sep 16, 2024 11:30am
